Patent law protects pharmaceutical innovation by granting 20-year exclusivity, enabling companies to recoup billions in R&D costs. The Hatch-Waxman Act balances this with a legal pathway for generics, saving U.S. healthcare $373 billion annually while driving down drug prices by up to 90%.